Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.

Authors :: Mercier C
Dahan L
Ouafik L
André N
Ciccolini J
Source :: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2010 Sep; Vol. 66 (9), pp. 959-60. Date of Electronic Publication: 2010 Jun 19.
Publication Year :: 2010

Subjects :: Adenine
Antimetabolites, Antineoplastic administration & dosage
Carcinoma, Non-Small-Cell Lung drug therapy
Confounding Factors, Epidemiologic
Cytosine
Deoxycytidine administration & dosage
Deoxycytidine pharmacokinetics
Humans
Lung Neoplasms drug therapy
Polymorphism, Genetic
Research Design
Gemcitabine
Antimetabolites, Antineoplastic pharmacokinetics
Carcinoma, Non-Small-Cell Lung metabolism
Cytidine Deaminase genetics
Deoxycytidine analogs & derivatives
Lung Neoplasms metabolism
Polymorphism, Single Nucleotide

Full Text Access

Tools